MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Bacterin Q1 sales bound 120 percent
Bacterin International Holdings Inc. (NYSE Amex:BONE) posted net income of $4.9 million, or 11 cents per diluted share, on sales of $6.0 million during the three months ended March 31. That compares with a loss of $1.6 million, or 0 cents per diluted share, on sales of $2.7 million during the same period last year.
Read more
Transgenomic losses widen despite uptick in sales
Transgenomic Inc. (OTC:TBIO) posted a loss of $2.8 million, or 6 cents per diluted share, on revenue of $7.5 million during the three months ended March 31. That compares with a loss of $324,000, or 1 cent per diluted share, on revenue of $5.4 million during the same period last year.
Read more
InSite Vision losses ease after sales boost
InSite Vision Inc. (OTC:INSV) reported a loss of $2.4 million, or 3 cents per diluted share, on revenue of $3.1 million during the three months ended March 31. That compares with a loss of $2.9 million, or 3 cents per diluted share, on revenue of $2.3 million during the same period last year.
Read more
Electromed sees bump in profts after strong sales
Electromed Inc. (NSDQ:ELMD) posted profits of $487,429, or 6 cents per diluted share, on sales of $5.2 million during the three months ended March 31. That compares with profits of $474,658, or 8 cents per diluted share, on sales of $4.2 million during the same period last year.
Read more
Tengion carries on without revenue
Tengion Inc. (NSDQ:TNGN) posted losses of $10.1 million, or $14.33 per diluted share, on no revenue during the three months ended March 31. That compares a loss of $7.0 million, or 45 cents per diluted share, on no revenue during the same period last year.
Read more
Kips Bay losses ease as company begins sales
Kips Bay Medical Inc. (NSDQ:KIPS) posted losses of $909,000, or 6 cents per diluted share, on sales of $110,000 during the three months ended April 2. That compares a loss of $3.5 million, or 27 cents per diluted share, on no revenue during the same period last year.
Read more
